|
|
Volumn 173, Issue 2, 1997, Pages 285-287
|
|
Differentiation therapy in acute promyelocytic leukemia: European experience
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CYTARABINE;
DAUNORUBICIN;
MERCAPTOPURINE;
RETINOIC ACID;
ACUTE MYELOBLASTIC LEUKEMIA;
BLOOD CLOTTING DISORDER;
CELL DIFFERENTIATION;
CLINICAL TRIAL;
CONFERENCE PAPER;
DRUG EFFICACY;
DRUG RESISTANCE;
DRUG SENSITIVITY;
HUMAN;
LEUKOCYTE ACTIVATION;
LEUKOCYTE DISORDER;
MAJOR CLINICAL STUDY;
MORTALITY;
PRIORITY JOURNAL;
RECURRENCE RISK;
REMISSION;
SURVIVAL RATE;
CELL DIFFERENTIATION;
CLINICAL TRIALS;
HUMANS;
LEUKEMIA, PROMYELOCYTIC, ACUTE;
TRETINOIN;
|
|
EID: 0030772260
PISSN: 00219541
EISSN: None
Source Type: Journal
DOI: 10.1002/(SICI)1097-4652(199711)173:2<285::AID-JCP37>3.0.CO;2-C Document Type: Conference Paper |
|
Times cited : (20)
|
|
References (18)
|
